After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Intellia Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Intellia Therapeutics Inc is $2.08B. A total of 0.85 million shares were traded on the day, compared to an average of 1.55M shares.
In the most recent transaction, BASTA JAMES sold 2,297 shares of NTLA for 32.99 per share on Mar 04 ’24. After the transaction, the EVP, General Counsel now owns 81,571 company shares. In a previous transaction on Mar 04 ’24, Clark Eliana sold 605 shares at 32.99 per share. NTLA shares that EVP, Chief Technical Officer owns now total 71,470.
Among the insiders who sold shares, Sepp-Lorenzino Laura disposed of 2,275 shares on Jan 08 ’24 at a per-share price of $28.87. This resulted in the EVP, Chief Scientific Officer holding 43,927 shares of NTLA after the transaction. In another insider transaction, LEONARD JOHN M sold 19,223 shares at $29.46 per share on Jan 03 ’24. Company shares held by the President and CEO now total 846,486.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, NTLA has a high of $47.48 and a low of $20.78.
As of this writing, NTLA has an earnings estimate of -$1.38 per share for the current quarter. EPS was calculated based on a consensus of 22.0 estimates, with a high estimate of -$1.02 per share and a lower estimate of -$1.58. The company reported an EPS of -$1.17 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. NTLA’s latest balance sheet shows that the firm has $748.69M in Cash & Short Term Investments as of fiscal 2021. There were $74.02M in debt and $125.83M in liabilities at the time. Its Book Value Per Share was $11.29, while its Total Shareholder’s Equity was $1.04B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NTLA is Buy with a score of 4.46.
